Trends in orphan medicinal products approvals in the European Union between 2010 –2022
Over the last twenty years of orphan drug regulation in Europe, the regulatory framework has increased its complexity, with different regulatory paths and tools engineered to facilitate the innovation and acce...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Lu ísa Bouwman, Bruno Sepodes, Hubert Leufkens and Carla Torre Tags: Research Source Type: research
More News: Internal Medicine | Rare Diseases